CPRC
MET icon

Consolidated Portfolio Review Corp’s MetLife MET Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,373
Closed -$360K – 254
2025
Q3 		$360K Sell
4,373
-473
-10% -$37.2K 0.05% 331
2025
Q2 		$390K Buy
4,846
+308
+7% +$23.8K 0.05% 293
2025
Q1 		$364K Sell
4,538
-63
-1% -$5.24K 0.06% 271
2024
Q4 		$377K Buy
4,601
+427
+10% +$35.5K 0.06% 264
2024
Q3 		$344K Buy
4,174
+47
+1% +$3.51K 0.08% 227
2024
Q2 		$290K Buy
+4,127
New +$295K 0.07% 240
2023
Q4 		– Sell
-4,374
Closed -$275K – 316
2023
Q3 		$275K Buy
+4,374
New +$272K 0.07% 251

Other funds holding MET

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Consolidated Portfolio Review Corp's MET Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of MetLife (MET) in Q4 2025, closing a stake of 4,373 shares — an estimated $360K sold.

Consolidated Portfolio Review Corp first reported a position in MET in Q3 2023 and held it in 7 quarters. The position peaked at $390K in Q2 2025. 1,447 funds tracked by Wall St. Rank hold MET as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining MetLife position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 4,373 MetLife shares in Q4 2025, an estimated $360K.
  • Consolidated Portfolio Review Corp first reported a position in MetLife in Q3 2023 and held it in 7 quarters.
  • Consolidated Portfolio Review Corp's MetLife position peaked at $390K in Q2 2025.
  • 1,447 funds tracked by Wall St. Rank held MetLife as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.